fludarabine phosphate has been researched along with Alveolitis, Fibrosing in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erslev, AJ; Kane, GC; McMichael, AJ; Patrick, H | 1 |
| Cervantes, F; Montserrat, E; Rozman, C; Salgado, C | 1 |
| Bluestein, M; Garewal, H; Greenberg, BR; Habib, MP; Hurst, PG; Paquin, M | 1 |
3 other study(ies) available for fludarabine phosphate and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate.
Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Humans; Male; Pulmonary Fibrosis; Respiratory Insufficiency; Vidarabine Phosphate | 1992 |
Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis.
Topics: Adult; Antimetabolites, Antineoplastic; B-Lymphocytes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Pulmonary Fibrosis; Risk Factors; Vidarabine Phosphate | 1990 |
Pulmonary toxicity associated with fludarabine monophosphate.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Humans; Leukemia, Lymphoid; Lung; Male; Middle Aged; Pulmonary Fibrosis; Vidarabine Phosphate | 1987 |